Skip to content
DataLookout
Menu

NCT07294313

Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 8 months later, enrollment reduced 40%.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment reduced: 400 → 240 participants Show 8 more changesShow less
    • Primary completion pushed from Sep 25, 2026 to Jun 1, 2027
    • Recruitment opened
    • Start date: Apr 25, 2026 to Nov 12, 2026
    • Eligibility criteria expanded, about 10 words
    • Study completion pushed from Nov 25, 2026 to Jun 25, 2027
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised
    • Publications: details revised at 6 of 6 entries
  2. Notable Start date: Dec 25, 2025 to Apr 25, 2026v3
  3. Minor Study title revised
    • Study description expanded, about 1 word
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

assessment of diagnostic capability of AI in AGA
Timeframe: 6 months

Secondary (2)

assessment of severity of androgenetic alopecia using AI
facilitation of AI assessment using macroscopic imagies

Arms and interventions

androgenetic alopecia

Patients diagnosed clinically and trichoscopically with androgenetic alopecia of both genders. The diagnosis of AGA requires fulfillment of the primary criterion, plus one or more of the secondary criteria, and absence of exclusion criteria: * Primary criterion Hair shaft thickness heterogeneity on the frontal and/or vertex scalp, defined as proportion of hairs \< 0.06 mm (including intermediate, thin, and vellus hairs) ≥20%. * Secondary criteria 1. Proportion of single hair follicle unit on the frontal and/or vertex scalp ≥30%. 2. Proportion of vellus hairs on the frontal and/or vertex scalp \>10%. 3. There are at least two other dermoscopic signs: brown peripilar sign, yellow dots,white dots, scalp honeycomb pigmentation * Exclusion criteria Black dots, broken hairs, exclamation mark hairs

normal controls

apparently normal participants not suffering from the following : 1. androgenetic alopecia 2. patchy hair loss. 3. cicatricial alopecia or diffuse alopecia areata 4. inflammatory scalp disorders (psoriasis, seborrheic dermatitis, lichen planopilaris and frontal fibrosing alopecia in a pattern distribution)

Sites

1 site in 1 country

  • Faculty of Medicine Cairo UniversityCairo, Cairo Governorate, Egypt